1. EG‐011 IS A NOVEL SMALL MOLECULE WITH IN VITRO AND IN VIVO ANTI‐TUMOR ACTIVITY AGAINST LYMPHOMA. (12th June 2019) Authors: Gaudio, E.; Spriano, F.; Tarantelli, C.; Guala, M.; Riveiro, E.; Golino, G.; Lupia, A.; Costa, G.; Rocca, R.; Cascione, L.; Jenni, S.; Tsai, Y.; Bornhauser, B.; Alcaro, S.; Paduano, F.; Trapasso, F.; Zucca, E.; Stathis, A.; Pazzi, N.; Cavalli, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Geophysical evidence for breakup volcanism in the Angola and Gabon passive margins. (June 2020) Authors: Fernandez, O.; Olaiz, A.; Cascone, L.; Hernandez, P.; Pereira, A. de F.; Tritlla, J.; Ingles, M.; Aida, B.; Pinto, I.; Rocca, R.; Sanders, C.; Herrá, A.; Tur, N. Journal: Marine and petroleum geology Issue: Volume 116(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC.04.2 PERSONALIZED DOSIMETRY STRONGLY AFFECT RESPONSE TO TARE AND SURVIVAL IN PATIENTS WITH INTERMEDIATE AND ADVANCED HCC. (September 2021) Authors: Martelletti, C.; Ricotti, A.; Berchialla, P.; Marengo, A.; Morello, E.; Richetta, E.; Rocca, R.; Tabone, M. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC.04.3 SUCCESSFUL THERAPY WITH DIRECT ANTIVIRAL AGENTS AND EARLY INTRAHEPATIC HEPATOCELLULAR CARCINOMA RECURRENCE: A MATCH-CONTROLLED STUDY. Issue 2 (15th March 2018) Authors: Diotallevi, M.; Forchino, F.; Russolillo, N.; Ferrero, A.; Rocca, R.; Tabone, M. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC.07.2 DOWNSTAGING UNRESECTABLE LOCALLY ADVANCED HEPATOCELLULAR CARCINOMA BY 90-YTTRIUM RADIOEMBOLIZATION: A SINGLE CENTER EXPERIENCE. (25th March 2019) Authors: Martelletti, C.; Diotallevi, M.; Calvo, A.; Russolillo, N.; Ferrero, A.; Rocca, R.; Tabone, M. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P.07.1 SWITCHING FROM INFLIXIMAB ORIGINATOR TO A FIRST BIO SIMILAR IS SAFE AND EFFECTIVE. A SINGLE CENTER SERIES WITH THROUGH LEVELS AND ANTI-DRUG ANTIBODIES DETERMINATION. Issue 2 (15th March 2018) Authors: Daperno, M.; Guiotto, C.; Italia, A.; Lavagna, A.; Negri, A.; Ercole, E.; Cosimato, M.; Rigazio, C.; Rocca, R. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Transcriptome and computational analysis assess the anti-tubulin activity of [1, 2]oxazole derivatives in lymphoma. (October 2022) Authors: Barreca, M.; Spanò, V.; Rocca, R.; Bivacqua, R.; Maruca, A.; Montalbano, A.; Raimondi, M.V.; Tarantelli, C.; Gaudio, E.; Cascione, L.; Rinaldi, A.; Bai, R.; Prota, A.; Abel, A.C.; Steinmetz, M.; Alcaro, S.; Hamel, E.; Bertoni, F.; Barraja, P. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗